AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Short guide to identifying dividend ETFs with the absolute lowest fees and what to consider beyond price.
27,457 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
UBS uMINT yield-bearing collateral is now live on Bybit through a three‑party workflow, turning idle cash into produc...
Ethereum trades at a level that many long-time holders never imagined, sparking questions about the next move. This a...
A growing cohort of high-earning workers is leveraging the Mega Backdoor Roth Strategy to build Roth balances inside ...
European regulators press Binance on MiCA licensing as Greece withdraws its application and talks with Ireland and La...
Bitcoin weakness pushes STRC to new lows as strategy's Saylor acknowledges 'volatility' as a real market test. This g...
Fighting over the Strait of Hormuz continues even after a ceasefire extension. The U.S. and Iran clash as Tehran pres...
A dramatic IPO debut gave SpaceX stock a strong start, but a recent pullback has investors weighing whether this dip ...
A government-backed AI initiative is building a data backbone to test nutrition-focused ideas in farming. Early pilot...
Retail traders who chased celebrity-backed crypto deals tied to a high-profile political name are confronting losses ...
SpaceX stock after falling has sparked debates among investors who chase high-growth tech with aerospace visibility. ...
TeraWulf stock this year has surged as the company pivots from crypto mining to long-term compute infrastructure afte...